Cargando…
Predicting time to medication access for hematologic malignancies: the impact of an integrated specialty pharmacy and limited distribution drug networks
Background: Barriers to accessing oral oncolytic therapy include insurance authorization, high copays and limited distribution drug (LDD) networks. In September 2015, a pharmacist joined an outpatient hematology clinic to facilitate timeliness of medications (for which the pharmacy has access) dispe...
Autores principales: | Zuckerman, Autumn D., Peter, Megan E., Starks, Samuel, Maulis, Matthew, Declerq, Josh, Choi, Leena, Jagasia, Madan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764336/ http://dx.doi.org/10.1080/21556660.2019.1658326 |
Ejemplares similares
-
Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy
por: Peter, Megan E, et al.
Publicado: (2021) -
Return to Sport and Performance After Microfracture in the Knees of National Basketball Association Players
por: Harris, Joshua D., et al.
Publicado: (2013) -
Reconstruction of Hyaline Cartilage Deep Layer Properties in 3-Dimensional Cultures of Human Articular Chondrocytes
por: Nanduri, Vibudha, et al.
Publicado: (2014) -
Development of a Valid and Reliable Knee Articular Cartilage Condition–Specific Study Methodological Quality Score
por: Harris, Joshua D., et al.
Publicado: (2014) -
Clinical Outcome 3 Years After Autologous Chondrocyte Implantation Does Not Correlate With the Expression of a Predefined Gene Marker Set in Chondrocytes Prior to Implantation but Is Associated With Critical Signaling Pathways
por: Stenberg, Johan, et al.
Publicado: (2014)